Invitrolize
Invitrolize provides innovative 3D alveolar in vitro model.
Invitrolize is a business in 3d technology, biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2022.
Within the 3d technology, biotechnology space, the company focuses on its core offering rather than a broad product line.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Grant.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $5K.
| Sector | 3D Technology, Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $50,000 |
Website: invitrolize.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account